XBIO
Xenetic Biosciences Inc
NASDAQ: XBIO · HEALTHCARE · BIOTECHNOLOGY
$3.03
+1.00% today
Updated 2026-04-30
Market cap
$6.87M
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$2 – $14
Volume
0.0M
Xenetic Biosciences Inc (XBIO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |